It is the most decisive prognostic factor for GBM. IDH-mutant astrocytoma (now termed IDH-mutant astrocytoma, CNS WHO grade 4) has a significantly better prognosis than IDH wild-type astrocytoma (classic GBM). Here, IDH1 is linked to astrocytoma (excluding glioblastoma).